Positive headline results for AT278 clinical trial | Company Announcement
Investegate announcements from Positive headline results for AT278 clinical trial
Source: investegate.co.uk
📰 Aspart Formulation News
Aspart Formulation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aspart Formulation. Real-time updates on events, politics, business and more.
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
Arecor Therapeutics plc AT278 ULTRA-CONCENTRATED ULTRA-RAPID ACTING INSULIN DEMONSTRATES SUPERIORITY IN PHASE I CLINICAL TRIAL IN OVERWEIGHT AND OBESE PEOPLE WITH TYPE 2 DIABETES AT278 demonstrates...
Source: marketscreener.com
Investegate |Arecor Therapeutics Announcements | Arecor Therapeutics: Arecor Publishes Data for AT278 in Diabetes Care
Investegate announcements from Arecor Therapeutics, Arecor Publishes Data for AT278 in Diabetes Care
Source: investegate.co.uk